Specialty Pharmacy

Enzyme associated with metabolic programming may lead to new treatments.

Company again selected as limited distribution pharmacy provider.

The FDA is seeking comments on 28 new and 15 revised recommendations providing product-specific guidance on the design of bioequivalence studies to support Abbreviated New Drug Applications (ANDAs).

Researchers examine the potential of creating new eggs with stem cells.

Narcotics are not recommended for managing chronic pain in children with inflammatory bowel disease, due to gastrointestinal side effects and potential dependence. Nevertheless, researchers have uncovered that long-term narcotic use is more than twice as prevalent in pediatric IBD patients compared with the general population.

Study examines how side effects from commonly used antibiotics effect mitochondria of cancer cells.

Mosquito-borne virus causes joint pain and swelling similar to rheumatoid arthritis.

The FDA today approved Eisai's kinase inhibitor, lenvatinib (Lenvima), for the treatment of differentiated thyroid cancer in patients whose disease progressed despite receiving radioactive iodine therapy.

Diabetics who took metformin saw a decreased chance of developing adenocarcinoma.

Following widespread concerns about counterfeit pharmaceuticals in the early 2000s, the FDA and individual states began reconsidering the design of the pharmaceutical supply chain.

A new Affordable Care Act initiative from HHS will better coordinate cancer care with the intention of improving the quality of care provided and reducing the money spent on healthcare.

Scientists map pathological progress of disease.

Spontaneous cure achieved in first person documented with WHIM Syndrome.

Annual rate of primary tumor removal has decreased since 1988.

Cells found to hijack vitamin D receptors to repair damage caused by therapy.

Raulo Frear, PharmD, general manager of OmedaRx, discusses the ramifications of biosimilars hitting the US market.

Trend reflects growing tobacco epidemic among women.

Biological process may lead to failure of embryo to attach to uterine wall.

Avella Specialty Pharmacy announced today that it has been selected by Pfizer as one of the limited groups of specialty pharmacies authorized to distribute the manufacturer's breakthrough breast cancer drug-Ibrance (palbociclib)-which has just received fast-tracked approval from the FDA.

Antiretroviral therapy has led to remarkable improvements in HIV-infected individuals. By suppressing HIV RNA to

Efficacy and safety demonstrated in models of aggressive leukemia.

Entry of web site into particular market correlates with increase in new cases.

Changes address concerns that the process to access investigational drugs was too difficult.

The first comprehensive consulting solution for integrated specialty drug management.

A recent study has identified how chronic hepatitis infection can pave the way to liver cancer.

Amgen has announced positive results of a phase 3 study evaluating its investigational drug, ABP 501, a biosimilar candidate to AbbVie's fully human anti-tumor necrosis factor alpha monoclonal antibody, adalimumab, in patients with moderate-to-severe rheumatoid arthritis.

Death risk twice as high for survivors who smoke compared with non-smokers.

Use of appropriate technology in the pharmaceutical supply chain can help reduce costs to organizations and improve care for patients.

Avella Specialty Pharmacy announced today that it has been selected by GlaxoSmithKline as one of a select group of pharmacies authorized to continue to distribute Benlysta, a medication approved by the FDA for the treatment of systemic lupus erythematosus in patients who have previously received other therapies.

The news of Margaret A. Hamburg, MD, resigning from her long-standing post as FDA Commissioner stirred memories of her success with improving access to emergency contraception, but more so her struggles with regulating drug compounding following a deadly fungal meningitis outbreak traced to a compounding pharmacy's tainted drugs.